替卡西林

HPLC法测定替卡西林钠的含量及有关物质

Study on the determination of Ticarcillin disodium and testing of related substances by HPLC

pH值对替卡西林钠-克拉维酸钾与药物配伍产生沉淀的影响

Effect of pH value to the precipitate in the compatibility of Ticarcillin / Clavulanate acid with other drugs

结果替卡西林钠-克拉维酸钾与pH较低的左氧氟沙星、阿米卡星配伍产生沉淀，加碱性试液pH升高后，溶液变澄清。

Results Precipitate happened in the compatibility of Ticarcillin / Clavulanate acid with low pH drugs such as Levofloxacin and Amikacin . The precipitate was dissolved by adding sodium hydroxide solution .

在ICU，鲍曼不动杆菌对亚胺培南暂无耐药性，其次对头孢吡肟、替卡西林/克拉维酸、哌拉西林/三唑巴坦和阿米卡星的耐药率分别为18%、29%、35%和38%。

The Acinetobacter baumannii have no drug resistance to imipenem in ICU at this time , The drug resistant rate of A baumannii to Cefepime , ticarcillin / clav , piperacillin / tazobactan , and amikacin is 18 % , 29 % , 35 % , and 38 % respectively .

高效液相色谱法测定替卡西林钠的含量及其有关物质

Determination of Ticarcillin Sodium and Related Substances by HPLC

替卡西林/克拉维酸和头孢他啶治疗中重度感染41例

Treatment of moderate and severe infection with ticarcillin / clavulanic acid versus ceftazidime in 41 patients

对抗生素敏感≥40%的抗生素为羧苄西林、美洛西林、甲氧苄啶、头孢他啶、替卡西林、替卡西林/克拉维酸。

Antibiotics with more than 40 % sensitivity rates were carbenicillin , mezlocillin , trimethoprim , ticarcillin , ticarcillin / clavulanic acid .

替卡西林克拉维酸钾阿莫西林克拉维酸钾治疗下呼吸道感染成本-效果分析

Cost Effectiveness Analysis of Different Methods with Ticarcillin / clavulanate Potassium and Amaxicillin / clavulanate Potassium in the Treatment of Lower Respiratory Infection

目的：比较替卡西林克拉维酸和头孢他啶治疗中重度感染的疗效及安全性。

Objective : To compare the clinical efficacy and safety profile of ticarcillin / clavulanic acid and ceftazidime in treatment of moderate and severe infection .

而耐药率最高的是氨苄西林（100.0%）、复方新诺明（98.7%）和替卡西林（98.7%）。

The antibiotics with highest drug sensitivity rate was ampicillin ( 100 % ), SMZ-TMP ( 98.7 % ) and ticarcillin ( 98.7 % ) .

目的：探讨不同治疗方法应用注射用替卡西林克拉维酸钾，阿莫西林克拉维酸钾片剂在下呼吸道感染治疗中的经济效果。

Objective : To investigate the economical way and effectiveness in different methods with Ticarcillin / clavulanate potassium and Amaxicillin / clavula-nate potassium in the treatment of lower respiratory infection .